Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Venanzi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Physiological Chemistry and Physics and Medical NMR|January 1, 1989
Residual DNA-bound proteins are a source of in vitro transcription inhibitor peptidesF M Venanzi
Nature|January 4, 1990
Mummy RNA lasts longerF M Venanzi, F Rollo
Genetical Research|December 1, 1991
Nucleic acids in mummified plant seeds: biochemistry and molecular genetics of pre-Columbian maizeF Rollo, F M Venanzi, A Amici
Cancer Immunology, Immunotherapy : CII|January 6, 1999
Genetic immunization against neu/erbB2 transgenic breast cancerA Amici, F M Venanzi, A Concetti
Annals of the New York Academy of Sciences|November 27, 1995
neu/HER-2 cDNA vaccination and pregnancy lossF M Venanzi, C Petrelli, A Concetti, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNAA Concetti, A Amici, C Petrelli, et al.
Immunology Letters|August 11, 1998
Binding of feline immunodeficiency viral gag-p24 polypeptide to nonimmune IgsA Amici, A Smorlesi, A Concetti, et al.
Vaccine|March 31, 2010
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic miceF M Venanzi, A Barucca, K Havas, et al.
Biological Chemistry Hoppe-Seyler|June 1, 1994
Immunorecognition of ring skeleton of taxanes by chicken egg yolk antibodiesA Concetti, E Ripani, L Barboni, et al.
Molecular Biotechnology|July 17, 2014
Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigenA Barucca, M Capitani, M Cesca, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Physiological Chemistry and Physics and Medical NMR|January 1, 1989
Residual DNA-bound proteins are a source of in vitro transcription inhibitor peptidesF M Venanzi
Nature|January 4, 1990
Mummy RNA lasts longerF M Venanzi, F Rollo
Genetical Research|December 1, 1991
Nucleic acids in mummified plant seeds: biochemistry and molecular genetics of pre-Columbian maizeF Rollo, F M Venanzi, A Amici
Cancer Immunology, Immunotherapy : CII|January 6, 1999
Genetic immunization against neu/erbB2 transgenic breast cancerA Amici, F M Venanzi, A Concetti
Annals of the New York Academy of Sciences|November 27, 1995
neu/HER-2 cDNA vaccination and pregnancy lossF M Venanzi, C Petrelli, A Concetti, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNAA Concetti, A Amici, C Petrelli, et al.
Immunology Letters|August 11, 1998
Binding of feline immunodeficiency viral gag-p24 polypeptide to nonimmune IgsA Amici, A Smorlesi, A Concetti, et al.
Vaccine|March 31, 2010
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic miceF M Venanzi, A Barucca, K Havas, et al.
Biological Chemistry Hoppe-Seyler|June 1, 1994
Immunorecognition of ring skeleton of taxanes by chicken egg yolk antibodiesA Concetti, E Ripani, L Barboni, et al.
Molecular Biotechnology|July 17, 2014
Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigenA Barucca, M Capitani, M Cesca, et al.
Pageof 2